Serosurvey for vaccine-preventable diseases among adult refugees
Completed
- Conditions
- immune systemprotection against diseases10019815
- Registration Number
- NL-OMON43434
- Lead Sponsor
- RIVM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 850
Inclusion Criteria
The person is registered as refugee at an emergency accommodation for refugees
The person is between 18 and 45 years of age
The person originates from any of the following countries: Afghanistan, Iran, Iraq, Eritrea, Ethiopia, Syria
The person is able to provide informed consent
Exclusion Criteria
The person refuses to participate in the study
The person is unable to provide informed consent (e.g. due to language barriers)
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The age-specific seroprevalence (immunity) for selected vaccine-preventable<br /><br>diseases among adult refugees between 18-45 years of age.</p><br>
- Secondary Outcome Measures
Name Time Method <p>The prevalence of viral hepatitis B and C infection. The parameters tested for<br /><br>are:<br /><br>- Hepatitis B virus: Anti-HBc, HBsAg, anti-HBs, HBV-DNA (if HBsAg is positive)<br /><br>- Hepatitis C virus: Anti-HCV, HCV-RNA (when anti-HCV is positive)</p><br>